News

Showing ##res## items
Active Filters:
  • (Reuters Health) - In men with localized prostate cancer discovered because they had symptoms or noticed during a work-up for another medical problem, radical prostate surgery leads to an average of three extra years of life compared to a "watchful waiting" approach, researchers say. The benefit of surgery was most...
  • New, less toxic cancer treatments are emerging, but don’t expect chemo to disappear anytime soon. Immunotherapy is one type of new cancer treatment that could someday make chemotherapy a thing of the past.  When Mary Olsen received a diagnosis of chronic lymphocytic leukemia, the most common type of leukemia in adults...
  • FRIDAY, Dec. 7, 2018 (HealthDay News) -- Younger breast cancer patients who have one or both breasts removed have lower levels of satisfaction and well-being than those who have breast-conserving surgery, a new study finds. The study included 560 women diagnosed with breast cancer by age 40. Of those, 28 percent had...
  • NEW YORK (Reuters) - When we were told our son had a potentially life-threatening brain tumor, our family was lucky to have world-class doctors and hospitals close to home and health insurance that covered nearly all his medical expenses and prescription drug costs. These resources helped us make a difficult decision...
  • About one-third of GoFundMe campaigns are medical fundraisers. A new study in The Lancet, a prestigious medical journal, found that at least 13,600 people have donated to GoFundMe campaigns raising money for unproven cancer treatments. Jeremy Snyder, one of the study's authors, told Business Insider that crowdfunding...
  • At first glance, the idea of stopping cancer treatment might seem strange. Why wouldn’t you want doctors to use every tool at their disposal to beat this deadly disease? But decisions about cancer treatment aren’t always that simple — or easy, says psychosocial oncologist Joel Marcus, PsyD. Here are some things to...
  • WEDNESDAY, Nov. 28, 2018 (HealthDay News) -- Truxima (rituximab-abbs) has been approved by the U.S. Food and Drug Administration as the first biosimilar to the non-Hodgkin's lymphoma drug Rituxan, the agency said today. Truxima, as with Rituxan, is approved to treat adults with CD20-positive, B-cell non-Hodgkin's...
  • Nov 2 (Reuters) - Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation who had been previously treated for an aggressive form of the disease. The treatment, Lorbrena, is designed to treat advanced non-small cell lung cancer in...
  • (Reuters Health) - Most older women who get chemotherapy for breast cancer do not experience problems with cognition in the first two years after diagnosis and treatment, a new study finds. But researchers did find one small subset of women who suffered some declines in attention, mental processing speed and decision...
  • Heat can be an incredibly simple, yet powerful, way to boost the effects of chemotherapy and radiation treatments for cancer. More than 5,000 years ago, doctors in ancient Egypt used heat to treat cancer. Today, cancer experts have refined the delivery of heat — a technique called hyperthermia — to improve radiation...
  • (Reuters Health) - - A web-based tool can let a man with prostate cancer see how thousands of other men in his situation have chosen to be treated, which may help him better understand his own options, a U.S. study suggests. Early-stage prostate cancer may not need treatment right away, or ever, because these tumors...
  • Cancer has an insidious talent for evading the natural defenses that should destroy it. What if we could find ways to help the immune system fight back? It has begun to happen. The growing field of immunotherapy is profoundly changing cancer treatment and has rescued many people with advanced malignancies that not...
  • NEW YORK (Reuters Health) - Whether a female breast cancer survivor receives an aromatase inhibitor (AI) or tamoxifen should be based on the drug's effectiveness against recurrence, but her risk of venous or arterial disease should also be considered, researchers say. "Our systematic review reported consistent trial...
  • The actress’s recent claim that a stem cell procedure helped her “regrow” a breast after battling cancer isn’t just inaccurate, it’s not currently possible. When celebrity advocates like Suzanne Somers spread misinformation, they harm the communities they’re trying to help. Actress Suzanne Somers isn’t afraid to let...
  • TUESDAY, Oct. 30, 2018 (HealthDay News) -- Despite evidence to the contrary, four in 10 Americans believe alternative therapies can cure cancer, a new survey finds. Research shows that cancer death rates are much higher among patients who use only alternative therapies than among those who receive standard cancer...
  • (Reuters Health) - Patients, their families and friends may see clinical trial research as important, yet they don't know much about the research process and see trial participation as burdensome, a new study suggests. About 85 percent of respondents in the new study said clinical research is important to developing...
  • (Reuters Health) - Cancer drugs that keep tumors from growing may not lead to better quality of life for patients, a new study suggests. "In countries where patients need to pay co-pays, they can use up all their savings in order to get access to those expensive new drugs and in the end, they may not extend their...
  • How one woman fought for her family, and her health, after being diagnosed with triple-negative breast cancer while pregnant. Getting the right advice after being diagnosed with breast cancer was a matter of life and death for Stephanie Hosford and her daughter. She didn’t know it yet, but finding a lump in her breast...
  • WEDNESDAY, Oct. 3, 2018 (HealthDay News) -- Many older breast cancer patients might worry that they will be struck by "chemo brain" after their treatments, but a new study suggests that only those who carry a gene linked to Alzheimer's face that risk. Researchers found that breast cancer survivors carrying the APOE4...
  • TUESDAY, Oct. 2, 2018 (HealthDay News) -- Almost 43 percent of patients diagnosed with breast cancer presenting to a National Cancer Institute (NCI)-designated cancer center for a second opinion have a change in diagnosis, according to a study published in the October issue of the Annals of Surgical Oncology. Denise...